Elanco Animal Health Incorporated Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
Elanco Animal Health Incorporated (ELAN) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2023-03-01
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $0.00.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2020 was $3.00M, a 40.00% decline from fiscal 2019.
- Elanco Animal Health Incorporated unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2019 was $5.00M, a 66.67% increase from fiscal 2018.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | |
| 2020-12-31 | $3.00M 10-K · filed 2023-03-01 | $3.60M 10-K · filed 2021-03-01 |
| 2019-12-31 | $5.00M 10-K · filed 2022-02-28 | $4.30M 10-K · filed 2020-02-28 |
| 2018-12-31 | $3.00M 10-K · filed 2021-03-01 | |
| 2017-12-31 | $4.00M 10-K · filed 2020-02-28 | |
| 2016-12-31 | $7.10M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |